Johnson And Johnson (JNJ) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 28 2026 to Jun 29 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Johnson and Johnson  (NYSE: JNJ)


Johnson And Johnson's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Johnson And Johnson's ROI in the second quarter of 2026?
Johnson and Johnson achieved a return on average invested assets (ROI) of 13.81 % in its second quarter of 2026, which is below Johnson And Johnson's average return on investment, which stands at 15.07%.

ROI has improved compared to 13.5% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 83 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 622 to 635.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Investment Change TTM 7.01 % 16.15 % 22.39 % 22.47 % 16.17 %
Y / Y Net Income Change TTM -7.17 % -3.53 % 147.93 % 240.37 % 383.59 %
Investment (TTM) in Millions 146,166 161,577 138,293 163,303 160,032
Return On Investment (TTM) 13.81 % 13.5 % 17.37 % 16.57 % 15.92 %
JNJ's Overall Ranking # 635 # 622 # 328 # 364 # 354
Seq. Investment Change TTM -2.22 % 0.98 % 1.81 % 6.46 % 6.13 %
Seq. Net Income Change TTM -0.01 % -21.5 % 6.71 % 10.85 % 3.9 %
Net Income (TTM) in Millions 21,037 21,040 26,804 25,119 22,661

JNJ Company Profile >> Back to JNJ Roi Comparisons >> See Annual JNJ Return On Investment



Return On Investment JNJ's Ranking
Within: No.
Industry # 34
Sector # 84
Overall # 635

Return On Investment Statistics
High Average Low
30.31 %
15.07 %
0.99 %
(Jun 30 2024)   (Apr 01 2018)



  News about Johnson and Johnson Return on Investment ROI

Johnson & Johnson Appoints Eugene A Woods as New Board Member Amidst Declining Stock Performance

November 30, 2023

Johnson and Johnson Appoints Eugene A. Woods as New Board Member Amidst Declining Stock Performance
Johnson and Johnson, a leading healthcare company, has announced the appointment of Eugene A. Woods, MBA, MHA, Chief Executive Officer of Advocate Health, to its Board of Directors. This move comes at a critical time for the company, as its stock performance has been experiencing a steady decline.
Joaquin Duato, Chairman and Chief Executive Officer of Johnson and Johnson, expressed his confidence in the appointment, stating, Mr. Woods is an exceptional addition to Johnson and Johnson s Board of Directors. With an impressive career in leading and transforming healthcare systems, his focus on delivering high-quality care aligns with the company s commitment to excellence.





Financial Statements
Johnson And Johnson's II. Quarter Investments $ 146,166 Millions JNJ's Balance sheet
Johnson And Johnson's II. Quarter Income $ 5,534 Millions Quarterly JNJ's Income Statement
JNJ's Income by Division See JNJ's Income by Division


JNJ Annual Return On Investment (Dec 28 2025)
2025		 (Dec 29 2024)
2024		 (Dec 31 2023)
2023		 (Jan 01 2023)
2022		 (Jan 02 2022)
2021
Total Investments in Millions 138,293 127,335 118,083 125,202 129,305
Y / Y Investment Growth 8.61 % 7.84 % -5.69 % -3.17 % 3.29 %
Net Income in Millions 26,804 14,066 35,153 17,941 20,878
Y / Y Net Income Growth 90.56 % -59.99 % 95.94 % -14.07 % 41.89 %
Annual Return On Investment 19.38 % 11.05 % 29.77 % 14.33 % 16.15 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 19.38 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
JNJ's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for JNJ's Competitors
Subscribers only: Roi for Johnson And Johnson's Suppliers
Subscribers only: Return On Investment for JNJ's Customers

Other Ratios
JNJ's Roa JNJ's Inventory Turnover Ratio JNJ's Growth Rates JNJ's Dividend Statistics
JNJ's Profitability Ratios JNJ's Asset Turnover Ratio JNJ's Dividend Growth
JNJ's Roe JNJ's Valuation Ratios JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 28 2026, within Healthcare Sector ROI
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %

Date modified: 2026-09-26T07:18:34+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.